Chronic kidney disease (CKD) is a slow health problem that affects how well your kidneys clean your blood. It has five stages ...
Novel Aldosterone Synthase Inhibitor Lorundrostat Shows Promise for Uncontrolled Hypertension in CKD
A new aldosterone synthase inhibitor added to SGLT2 inhibitors reduces uncontrolled blood pressure in patients with chronic kidney disease, according to the results of a phase 2 trial.
News-Medical.Net on MSN
New study reveals CKD affects nearly 800 million adults worldwide
The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million ...
It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most benefit from ...
CKD now affects 788 million adults globally, killing 1.48 million each year—linked to diabetes, hypertension, and ageing ...
News-Medical.Net on MSN
Using estimated risks and preferences to justify intensive BP control in CKD patients
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney ...
Other risk factors for kidney disease include chronic infections, autoimmune disorders, and certain genetic variants. The new ...
The growing burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been a major driver of demand for ...
A new study published in the Journal of American Heart Association found that the risk of sudden cardiac arrest (SCA) may be ...
Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose ...
If you receive a denial letter from your insurer, seek legal advice before appealing the decision, says a leading disability ...
ICMR-RMRC Bhubaneswar is set to launch Odisha's first state-wide study on chronic kidney disease prevalence, pending funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback